Highlights Roche Holding AG Swiss Exchange

Equities

RO

CH0012032113

Real-time Estimate Cboe Europe Other stock markets 09:56:47 2024-06-10 am EDT			5-day change	1st Jan Change
266.9 ^CHF	-0.71%		+3.91%	+1.76%

12:44pm	Roche's Lung Cancer Drug Notches EU Win After 'Unprecedented' Late-stage Study Results	MT
09:27am	Roche: FDA clearance for virus test	CF

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Roche's Lung Cancer Drug Notches EU Win After 'Unprecedented' Late-stage Study Results	06:44am	MT
Roche: efficacy of Evrysdi in spinal muscular atrophy	Jun. 07	CF
Roche's Five-year Data Confirms Efficacy, Safety of Evrysdi Drug for Spinal Muscular Atrophy in Children	Jun. 07	MT
Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	Jun. 07	MT
Astra's Enhertu breast cancer trial shows 'unprecedented' results	Jun. 02	RE
Astra's Enhertu delays breast cancer in patients with low HER2 levels	Jun. 02	RE
Swiss Stocks Fall as Rate Jitters Intensify Amid Latest Inflation Data	May. 29	MT
Global markets live: BHP, Anglo American, Lenovo, Nvidia, Apple...	May. 29
Roche Holding AG Announces U.S. Food and Drug Administration Accepted the New Drug Application and Granted Priority Review to Inavolisib, an Investigational, Oral Therapy, in Combination with Palbociclib (Ibrance®) and Fulvestrant	May. 29	CI
Roche renews diagnostic partnership with Hitachi	May. 27	CF
Roche and Hitachi High-Tech Extend Their 46-Year Partnership, Paving the Way for Further Breakthroughs in Diagnostic Testing	May. 27	CI
UK Watchdog Launches Probe into Roche's LumiraDx Purchase	May. 24	MT
Roche, LumiraDx Deal Probed by U.K. Competition Watchdog	May. 24	DJ
Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test	May. 22	MT
Roche Receives FDA Device Designation for Blood Test Measuring Lp(a)	May. 22	CI
Europe stock pickers go old-school to ride the next wave in AI	May. 22	RE
FDA Grants Breakthrough Therapy Designation to Roche's Inavolisib for Advanced Hormone Receptor-Positive, Hormone-Positive, Hormon Receptor 2-Negative Breast Cancer with A PIK3CA Mutation	May. 21	CI
UK Competition Watchdog Considers Probe into Roche's Purchase of LumiraDx Business	May. 20	MT
UK'S CMA: INVITES COMMENTS ON ROCHE / LUMIRADX DEAL FROM ANY IN…	May. 20	RE
Health Care Up on Rotation to Sector From Rate-Sensitive Groups -- Health Care Roundup	May. 17	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am EDT

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am EST